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Abstract
Background: Burkholderia pseudomallei is a saprophyte in tropical environments and an
opportunistic human pathogen. This versatility requires a sensing mechanism that allows the
bacterium to respond rapidly to altered environmental conditions. We characterized a two-
component signal transduction locus from B. pseudomallei 204, mrgR and mrgS, encoding products
with extensive homology with response regulators and histidine protein kinases of Escherichia coli,
Bordetella pertussis, and Vibrio cholerae.
Results: The locus was present and expressed in a variety of B. pseudomallei human and
environmental isolates but was absent from other Burkholderia species, B. cepacia, B. cocovenenans,
B. plantarii, B. thailandensis, B. vandii, and B. vietnamiensis. A 2128 bp sequence, including the full
response regulator mrgR, but not the sensor kinase mrgS, was present in the B. mallei genome.
Restriction fragment length polymorphism downstream from mrgRS showed two distinct groups
were present among B. pseudomallei isolates. Our analysis of the open reading frames in this region
of the genome revealed that transposase and bacteriophage activity may help explain this variation.
MrgR and MrgS proteins were expressed in B. pseudomallei 204 cultured at different pH, salinity and
temperatures and the expression was substantially reduced at 25°C compared with 37°C or 42°C
but was mostly unaffected by pH or salinity, although at 25°C and 0.15% NaCl a small increase in
MrgR expression was observed at pH 5. MrgR was recognized by antibodies in convalescent sera
pooled from melioidosis patients.
Conclusion: The results suggest that mrgRS regulates an adaptive response to temperature that
may be essential for pathogenesis, particularly during the initial phases of infection. B. pseudomallei
and B. mallei are very closely related species that differ in their capacity to adapt to changing
environmental conditions. Modifications in this region of the genome may assist our understanding
of the reasons for this difference.
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Background
The saprophyte Burkholderia pseudomallei is an opportun-
istic pathogen that is capable of intracellular survival [1,2]
and causes melioidosis, a frequently fatal disease of
humans and animals, which can be difficult to diagnose
[3]. Although the pathogen is mainly distributed in the
soil and water of tropical regions, especially south-east
Asia and northern Australia, it is highly adaptable, nutri-
tionally versatile and able to survive and grow in a wide
range of environments [4-8]. The disease encompasses a
broad spectrum of clinical symptoms and outcomes,
including long periods of latency up to 62 years [9], and
affects the lives of many millions of people [10].
The pathogenesis of B. pseudomallei infections involves the
expression of cell-associated components such as lipopol-
ysaccharide, pili, extracellular polysaccharide, and flagella
[3] as well as secreted factors including toxins [11], pro-
tease [12], siderophore [13] and phospholipase [14].
Although capsular polysaccharide has been shown to
enhance the intracellular survival and virulence of the
pathogen, the role of this and other factors in pathogenic-
ity and host resistance has not been conclusively resolved
[15-17]. It is possible that pathogenesis involves the
expression of many genes that are regulated in response to
complex environmental signals.
Many bacterial pathogens possess signal transduction sys-
tems that are able to elicit adaptive responses to environ-
mental variations and consequently have an important
role in regulating the expression of genes that are crucial
for survival and infection [18]. The prevalence of two-
component transduction systems in a wide variety of bac-
terial species has stimulated interest and some limited
success in designing new classes of broad-spectrum anti-
microbials that can block these signalling pathways
[19,20]. The most attractive reason for targeting these sys-
tems, such as PhoP/PhoQ from Salmonella typhimurium
and BvgA/BvgS from Bordetella pertussis, is that they con-
trol the expression of genes required for infectivity and vir-
ulence in pathogenic bacteria [21]. Bacterial two-
component systems are typically composed of a trans-
membrane histidine protein kinase that serves as an envi-
ronmental sensor and a cytoplasmic response regulator
that uses reversible phosphorylation to regulate gene
expression in response to changing environmental condi-
tions [22,23].
Most, if not all, bacteria can respond and adapt to changes
in environmental conditions, such as temperature,
osmotic pressure and pH, by regulating gene expression
[24,25]. Understanding how these conditions affect the
expression of genes which can regulate an adaptive
response is important for improving our understanding of
opportunistic pathogens, such as B. pseudomallei, that are
able to survive a wide range of environmental variations.
In this study we report the identification of a two-compo-
nent signal transduction system from B. pseudomallei
encoding proteins most similar in structure to RcsB and
RcsC that regulate capsule synthesis in Escherichia coli. We
cloned and characterized the genes and examined their
expression under conditions that B. pseudomallei may
encounter during its life cycle. In order to more fully char-
acterize this region of the B. pseudomallei genome we
examined genetic variation downstream from the mrgRS
locus in a variety of B. pseudomallei isolates and show that
2 distinct groups of isolates can be distinguished.
Results and discussion
Identification of genes encoding a two-component signal 
transduction system
A DNA sequence from the coding region of a two-compo-
nent regulatory gene was amplified by PCR from B. pseu-
domallei 204 chromosomal DNA, subcloned into pUC18,
sequenced on both strands to confirm the identity,
labelled and used to probe B. pseudomallei λZAP and
λGEM-11 genomic DNA libraries. A λGT-11 genomic
library constructed from B. pseudomallei strain 204 by Dr
C. Davies, University of Plymouth was also screened.
Approximately 4000, 5000 and 8000 recombinant phage
plaques were screened from which 5, 3, and 2 positive
plaques were isolated from the λGEM-11, λZAP Express,
and λGT-11 libraries, respectively. Each was found to con-
tain identical sequence information in the regions of over-
lap (Figure 1). This work was initiated and completed well
before the B. pseudomallei genome sequence was pub-
lished, and was not based on any genome sequence infor-
mation.
Of the two open reading frames (ORFs) identified, one
(666 bp) designated mrgR for melioidosis agent regula-
tory gene regulator, possesses a promoter but lacks an
obvious transcriptional termination sequence after the
stop codon. The translated product (23,860 Da) shares
extensive similarity with a large family of response regula-
tors, particularly the RcsB proteins of Erwinia amylovora, E.
coli, and Salmonella typhi, and BvgA of Bordetella pertussis
(28–31% identity). A helix-turn-helix DNA binding
domain is located in the C-terminal portion (residues
158–215) which is a common feature of response regula-
tors of the LuxR/FixJ family of cytoplasmic transcriptional
regulators. In addition, the protein possesses conserved
residues that characterize this family, including Asp-61
which is believed to be phosphorylated, and Asp-15, Asp-
16, Thr-191, and Lys-202, which are believed to contrib-
ute to the acidic pocket for the phosphorylation site
[18,26]. These features strongly suggest that MrgR should
be assigned to the LuxR/FixJ family of transcriptional reg-
ulators that are located in the cytoplasm and are thought
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to bind to specific promoter sequences upstream of regu-
lated genes.
The second ORF (3237 bp) was designated mrgS for
melioidosis agent regulatory gene sensor and is tran-
scribed in the same direction as mrgR. The initiation
codon of mrgS overlaps by a single nucleotide with the ter-
mination codon of mrgR i.e. TGATG. This feature has been
described for genes encoding two-component regulator
systems from different bacterial species such as ompR/envZ
of E. coli [27] and irlRS operon of B. pseudomallei [28].
Eight nucleotides upstream from the ATG start codon and
in the distal portion of mrgR, there is a potential S-D
sequence (AAGGA) and 17 bp downstream from the stop
codon lies a 36 bp GC-rich inverted repeat (ΔG = -26 kcal)
which could act as a strong transcriptional terminator for
mrgS. The absence of secondary structure around the stop
codon of mrgR suggests that transcription does not termi-
nate at that point and the lack of an obvious promoter
region for mrgS suggests that transcription may be control-
led from the mrgR promoter and that both ORFs are tran-
scribed as a polycistronic unit.
The translated product of mrgS (118,267 Da) shares
homology with a family of two-component histidine
kinases that function by sensing environmental stimuli,
particularly RcsC of E. coli and also sensor kinases of S.
typhi and Vibrio cholerae (18–22% identity). RcsC is the
sensor regulator of capsule synthesis in E. coli and many
other species, including E. amylovora,P. mirabilis and S.
typhi [29]. MrgS possesses many of the features common
to this family of sensor proteins including two strongly
hydrophobic transmembrane sequences located in the N-
terminal portion of the protein between residues 29–49
and 322–342, and five blocks of conserved functional
subdomains located in the C-terminal portion of the pro-
tein including His-503 that is the proposed site of phos-
phorylation, and the N, G1 (DTGVG), F, and G2 (GTGLG)
boxes at positions 620, 647–651, 661 and 677–681,
respectively [30]. These motifs are presumed to form a
nucleotide-binding surface within the active site of the
molecule. In addition, several conserved Asp residues are
present in MrgS, at positions 860, 898, 903, 910 and 949,
and may contribute to the additional response regulator
domain that is a characteristic of hybrid histidine kinases
[31]. Like BvgS of B. pertussis, MrgS is a member of a fam-
ily of complex sensor proteins, the hybrid kinases, which
contain multiple cytoplasmic domains that are believed
to participate in a phosphorylation cascade in signal
transduction. The presence of two hydrophobic trans-
membrane domains separated by a large loop of 273
amino acids which may act as a periplasmic environmen-
tal monitor is appropriate for a sensor protein that lends
itself to signal transduction [18].
Because the deduced amino acid sequences of mrgR and
mrgS are most similar to the sequences of genes encoding
known response regulators and sensors, it has been
inferred that these two genes constitute a two-component
signal transduction system. Since the completion of our
work the B. pseudomallei genome sequence has been pub-
lished [32] and mrgR and mrgS are now known to corre-
Map of the mrgRS locus of the B. pseudomallei genome (GenBank accession no. DQ418486)Figure 1
Map of the mrgRS locus of the B. pseudomallei genome (GenBank accession no. DQ418486). Open reading frames and direction 
of transcription are marked (arrows). See text for details of mrgR and mrgS, ORFs1-4, and oligonucleotide probes FR1-3. E = 
EcoRI site, B = BclI site. The positions of the additional EcoRI site that is described in the text and which is present in many B. 
pseudomallei isolates, and the 450 bp bacteriophage-like insertion and 650 bp transposase-like sequence that accompany this 
extra restriction site, are indicated by dotted lines.
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spond to locus tags BPSL1633 and BPSL1634,
respectively, in the genome sequence of B. pseudomallei
K96243.
The mrgRS locus is present in B. pseudomallei but not 
other Burkholderia species
Southern hybridization analysis of genomic DNA
extracted from 19 isolates of B. pseudomallei derived from
environmental and clinical samples from different areas
of the world (Table 1), showed that all of the isolates pos-
sessed a single EcoRI fragment of ~4.3 kb in size (Figure
2a) corresponding to the EcoRI fragment spanning most
of the mrgRS locus. The locus was not detected in genomic
DNA from E. coli, Pseudomonas aeruginosa, Pseudomonas
fluorescens, or other Burkholderia species including the
closely related Burkholderia thailandensis (Figure 2b). We
compared the mrgRS locus from B. pseudomallei 204 with
the completed genome sequences for B. pseudomallei iso-
lates K96243 and 1710b and with the unfinished
sequences of a further 8 strains that are available on Gen-
Bank and found that there is some variation amongst the
different strains within this region of the genome.
Although the mrgR reading frame is preserved there are
modifications within the 5' region upstream from the
mrgR start codon that may have implications for the
expression of the gene. In some strains there are also mod-
ifications within the coding region of mrgS, including a
single nucleotide addition (nt 3051) that changes the
reading frame and adds 4 additional amino acids to the
last 61 residues of the C-terminus of MrgS and which may
have functional consequences. A search of the genome
sequences of 8 strains of the obligate pathogen Burkholde-
ria mallei which are available on GenBank, revealed that
2128 bp encompassing the entire mrgR gene sequence and
including 1319 bp upstream of the mrgR start codon, is
highly conserved in 4 of the 8 strains of this organism
(98% identity over 2128 bp). The full mrgR gene sequence
shares 100% identity with B. mallei. Apart from the initial
144 bp downstream from the start codon, the mrgS
sequence is absent from B. mallei and this feature may
contribute to its inability to adapt to conditions outside a
suitable host, in contrast with B. pseudomallei [33,34].
MrgR and MrgS are present in B. pseudomallei cell lysates 
but not culture supernatant
Strains of B. pseudomallei representing isolates from clini-
cal (112, 204, 576) and environmental (E8, 98, 216) sam-
ples were cultured at 37°C and whole cell lysates and
concentrated culture supernatants were prepared, proteins
were separated by SDS-PAGE, transferred to nitrocellulose
and probed with antibodies recognising MrgR and MrgS.
Anti-MrgR and anti-MrgS each recognized more than one
band on Western blots of whole cell lysates of all strains.
In all strains, anti-MrgR recognized 3 major bands close to
the expected size of MrgR, 24–28 kDa, as well as a strong
band of ~80 kDa (Figure 3). Members of the response reg-
ulator protein family are known to be phosphorylated at
specific residues [26] and because MrgR possesses the
same features as these proteins we propose that the 24–28
kDa bands may represent different phosphorylation states
of the MrgR protein. In some strains, bands of ~90 and/or
~150 kDa were faintly visible. Anti-MrgS strongly stained
a band of ~115 kDa, close to the predicted size of MrgS,
and another band of ~30 kDa (Figure 4). In some strains
a band of ~90–100 kDa was also visible. Preincubating
anti-MrgR and anti-MrgS with their cognate immunising
peptide, as described in the antibody specificity data sup-
plement (see Additional file 1), abolished all staining.
Hence additional bands possess the same epitope and
may represent either breakdown products of the 118 kDa
MrgS protein or, in the case of MrgR, an additional anti-
genically-related 80 kDa protein. MrgR and MrgS were not
detected in concentrated broth culture supernatant (result
not shown) supporting the suggestion that MrgR and
MrgS are not secreted proteins.
Convalescent sera from melioidosis patients reacts with 
MrgR
Western blots of whole cell lysates from 6 isolates of B.
pseudomallei that were probed with convalescent sera
pooled from 6 melioidosis patients (supplied by Vana-
porn Wuthiekanun, Wellcome Trust-Oxford University-
Mahidol University Tropical Medicine Research Pro-
gramme, Bangkok, Thailand) demonstrated strong anti-
body recognition of multiple components in all isolates
(see Additional file 4). Furthermore, Western blots of cell
lysates of E. coli expressing MBP-MrgR that were probed
with the same sera stained a band of ~60 kDa that was
present in soluble, insoluble, and amylose resin purified
extracts from bacteria that had been induced with IPTG
(Figure 5). A low level of recognition was evident in unin-
duced cell extracts, similar to that observed when Western
blots of the same cell extracts were probed with anti-MrgR.
The convalescent sera did not recognize purified MBP,
MBP-MrgS or any other E. coli components and no recog-
nition of MBP-MrgR was seen when Western blots of the
same extracts were probed with serum from an individual
not previously exposed to B. pseudomallei (data not
shown). This raises the possibility that MrgR may be
expressed by B. pseudomallei during melioidosis infection
although it is unclear how a regulatory protein that is not
apparently secreted in vitro would be exposed to the host
immune system and the presence of cross reactive
epitopes on related proteins can not be excluded.
Expression of MrgR and MrgS proteins under different 
growth conditions
B. pseudomallei 204, from which the mrgRS locus was
cloned and characterized, was cultured under a variety of
different conditions. A range of temperatures, pH and
BMC Microbiology 2006, 6:70 http://www.biomedcentral.com/1471-2180/6/70
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salinities were chosen to reflect a variety of natural and
host environments to which B. pseudomallei might be
exposed within the tropics [6]. Although B. pseudomallei
can grow over a wide range of variation in these parame-
ters, we obtained the highest yields of protein at 42°C, pH
6.8 and 0.5% NaCl. Substantial yields of protein were also
obtained at either 37 or 42°C, pH 5 and 0.15% NaCl, and
the lowest yields were recorded at pH 8. These observa-
tions support in vitro and in vivo studies showing that B.
pseudomallei readily adapts to acidic environments
[7,35,36] and has an optimum growth temperature in
vitro of 37–42°C [6]. Birds are considered to be relatively
resistant to B. pseudomallei infection [37] but the strong
growth at 42°C of all of the isolates of B. pseudomallei
Table 1: Bacterial strains used in this study
Strain Strain origin Sample Geographical origin Date Source
Burkholderia pseudomallei
E8 Environment Soil NE Thailand 1990 1
19 Environment Soil Singapore 1991 1
22 Environment Soil Burkina Faso 1973 2
25 Environment Soil Madagascar 1977 1
E25 Environment Soil Thailand - 1
33 Environment Manure France 1976 1
46 Human Blood NE Thailand 1988 1
53 Human Urine NE Thailand 1987 1
97 Environment Soil Australia - 1
98 Environment Soil Australia - 1
102 Environment Soil Australia - 1
112 Human Multiple NE Thailand 1992 1
204 Human Blood Thailand - 1
212 Environment Soil NE Thailand 1990 1
216 Environment Soil NE Thailand 1990 1
217 Environment Soil (wet) NE Thailand 1990 1
392 Human Pus NE Thailand 1989 1
426 Environment Soil Vietnam - 1
448 Environment Soil Vietnam - 1
576 Human Blood Thailand - 1
Hainan 1 (H1) Human Abscess China 1996 2
Hainan 2D (H2D) Human Abscess China 1996 2
Hainan 55 (H55) Human Abscess China 1996 2
Hainan 706 (H706) Human Abscess China 1996 2
Burkholderia thailandensis
E27 Environment Soil Thailand - 2
E38 Environment Soil Thailand - 2
E82 Environment Soil NE Thailand 1990 2
E255 Environment Soil NE Thailand - 2
E256 Environment Soil Thailand - 2
E260 Environment Soil Central Thailand 1993 2
Other Burkholderia species
B. cocovenenans LMG11626 2
B. plantarii LMG10908 2
B. vietnamiensis LMG6998 2
B. cepacia IIIa non-epidemic 2
B. vandii LMG10620 2
Other species
Pseudomonas aeruginosa 3
Pseudomonas fluorescens 3
Escherichia coli DH5α 3
1: David Dance HPA South West, Derriford, Plymouth; 2: Ty Pitt, Centre for Infections, HPA, Colindale, London; 3: University of Plymouth culture 
collection
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raises the possibility that birds might act as a reservoir of
B. pseudomallei and pose a risk for the transmission of
active melioidosis to other species [38].
The expression of the 24–28 kDa MrgR bands was sub-
stantially reduced when B. pseudomallei 204 was cultured
at 25°C compared with 37 or 42°C but was mostly unaf-
Southern blot hybridisation of EcoRI-digested genomic DNA from different bacterial species using a digoxigenin-labeled oligo-nucleotide probe for mrgRSFigur  2
Southern blot hybridisation of EcoRI-digested genomic DNA from different bacterial species using a digoxigenin-labeled oligo-
nucleotide probe for mrgRS: a) B. pseudomallei isolates, pMRG2 contains a 4.3 kb EcoRI fragment of B. pseudomallei genomic 
DNA, spanning most of the mrgRS locus, inserted in pUC18 and digested with EcoRI b) B. thailandensis, other Burkholderia spe-
cies, including B. cocovenenans (B. coco.), B. plantarii (B. plant.), B. vietnamiensis (B. viet.), B. cepacia (B. cep.) and B. vandii (B. van.), 
Pseudomonas aeruginosa (P. aer.), Pseudomonas fluorescens (P. fluo.) and E. coli. Lane M, λ-HindIII markers with molecular sizes (in 
kilobases) indicated on the left. See Table 1 for isolate details. All of the samples in the figure were separated on the same sin-
gle agarose gel, transferred to the same single nylon membrane, and hybridized in the same single hybridization tube using the 
same labeled probe. The image of the resulting single Southern blot is reproduced in the figure as 2 panels, a) and b), for con-
venience and clarity and therefore pMRG2 represents a positive control for all samples.
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fected by different pH or NaCl concentration, although at
25°C and 0.15% NaCl a small increase in expression was
observed at pH 5 (Figure 6). This was particularly evident
at 42°C, where the lower molecular weight band that we
believe represents the dephosphorylated form of MrgR is
absent, demonstrating that at higher temperatures the
gene is co-ordinately up-regulated. It is possible that at
least some of the observed effects could be explained by
differences in gene expression at different growth stages,
but because equivalent quantities of protein from each
sample were used in these studies and the expression of
the 80 kDa immunoreactive band was mostly unaffected
by pH, salt concentration or temperature then this possi-
bility seems unlikely. A similar response was observed for
MrgS expression (Figure 7).
Cloning and sequence analysis of mrgRS downstream 
flanking region
Four ORFs, referred to here as ORFs1-4, were identified
downstream from the mrgRS locus (Figure 1) and the con-
ceptual translations of each ORF were analysed. The
sequence and arrangement of the ORFs is available on
GenBank (accession no. DQ418486). We cloned,
sequenced and analyzed the genes well before the com-
pletion of the B. pseudomallei genome sequence, which is
now known to correspond to the region of the B. pseu-
domallei K96243 genome sequence containing locus tags
BPSL1635-1637. These locus tags do not exactly match
ORF2 and ORF3 that we have identified. Indeed, there are
differences in the nucleotide sequences and also in the
gene and protein annotations for this region of the two
completed genome sequences, B. pseudomallei K96243
and 1710b that are listed on GenBank. The strong tran-
scriptional termination sequence following the mrgS gene
suggests that the downstream sequences are transcribed
separately. ORF1 (BPSL1635) is immediately downstream
of mrgS and transcribed in the same direction and the pre-
dicted protein (31,527 kDa) is similar to sensor transduc-
tion proteins containing EAL (GluAlaLeu) domains, such
as the oxygen sensing protein of E. coli O157:H7 (31%
identity) and BvgR of B. pertussis (25% identity). EAL
domains are found in a wide variety of bacterial signalling
proteins where they can act to stimulate degradation of
the second messenger, cyclic di-GMP, and may function as
a diguanylate phosphodiesterase [39]. Enzymatically
Western blot probed with an affinity purified antibody, anti-MrgS, showing MrgS in cell lys tes from 6 sol tes f B. pseu-domallei grown at 37°CFigur  4
Western blot probed with an affinity purified antibody, anti-
MrgS, showing MrgS in cell lysates from 6 isolates of B. pseu-
domallei grown at 37°C. The isolate number is indicated 
above each lane. Lane M: molecular weight markers indicated 
in kilodaltons (kDa). See Table 1 for isolate details. Arrow 
indicates the expected position of the 118 kDa MrgS protein. 
Smaller bands may represent processed forms of MrgS. See 
text for details.
E8 98 11
2 21
6
20
4
57
6M
kDa
6
17
22
30
42
60
148
►
Western blot probed with an affinity purified antibody, anti-MrgR, showing the detection of MrgR in whole cell lysates from 6 is lates of B. ps ud mallei g ow  at 37°CFigure 3
Western blot probed with an affinity purified antibody, anti-
MrgR, showing the detection of MrgR in whole cell lysates 
from 6 isolates of B. pseudomallei grown at 37°C. The isolate 
number is indicated above each lane. Lane M: molecular 
weight markers indicated in kilodaltons (kDa). See Table 1 
for isolate details. Arrows indicate the expected position of 
the 24 kDa MrgR protein and slightly larger phosphorylated 
forms of MrgR. See text for details.
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active and inactive forms have been described [39] and
the variation in EAL domain sequences may reflect the
convergent evolution of successful structure-function
motifs rather than the usual primary sequence similarity.
This structure is conserved in the conceptual translation of
ORF1. Although the precise functions of many of these
proteins are unknown, their open reading frames are
within or are tightly linked to operons with well-defined
functions. For example, bvgR is required for regulation of
all known bvg-repressed genes in B. pertussis, and is located
on a separate regulatory unit immediately downstream
from the bvgAS locus encoding a two-component regula-
tory system that upregulates virulence gene expression in
B. pertussis [40]. The similarities between the genomic
organisation in bvgAS-bvgR and mrgRS-ORF1 together
with the fact that both BvgAS and MrgRS are members of
the two-component signal transduction family allows for
the possibility that ORF1 may also act to repress the mrgRS
locus.
Further downstream and in the reverse direction of the
complementary strand three open reading frames were
identified, ORF2, ORF3, and ORF4. For ORF2, the pre-
dicted protein (28,251 kDa) is similar to the arginine/ser-
ine rich regions of functionally diverse proteins that are
important for binding RNA and DNA and for protein-pro-
tein interactions [41], such as LigA of Burkholderia cenoce-
pacia (33% identity). The conceptual translation of ORF3
(16,856 kDa) is similar to a variety of transmembrane-
transport proteins, such as the ABC thiamine transporter
of Roseovarius nubinhibens (31% identity) and capsular
polysaccharide export protein of Rhodobacter sphaeroides
(28% identity), and possesses 2 transmembrane helices
(TopPRED2 scores 0.71 and 0.88). For ORF4 (BPSL1637),
the predicted protein (39,493 kDa) has a lipase (class 3)
domain spanning residues 103–252 and including the
lipase serine active site [42], GHSLG, located at positions
187–191. This protein lacks the features usually associ-
ated with a signal peptide, although this is not an essential
component for secretion [43], and is strongly predicted to
be secreted by non-classical mechanisms, SecP score =
0.933881 (B. pseudomallei isolate 204) and 0.930609 (B.
pseudomallei isolate 112) [44]. B. pseudomallei has been
shown to utilize a wide variety of lipid substrates [45,46]
and to confirm the presence of an extracellular lipase con-
centrated culture supernatants were prepared from all iso-
lates of B. pseudomallei (Table 1). Lipase activity was
determined to be present in all samples using the fluoro-
genic substrate 4-methylumbelliferyl oleate and so it is
possible that this gene could be expressed, secreted and
contribute to this lipase activity, either alone or in concert
with other molecules.
Expression of MrgR in B. pseudomallei 204 cultured under dif-ferent combinations of temperature, pH and NaCl concen-trationFigure 6
Expression of MrgR in B. pseudomallei 204 cultured under dif-
ferent combinations of temperature, pH and NaCl concen-
tration. Western blots of whole cell lysates were probed 
with anti-MrgR. The identity of each lane is indicated at the 
top. Lane M: molecular weight markers indicated in kilodal-
tons (kDa). Arrows indicate the expected position of the 24 
kDa MrgR protein and slightly larger phosphorylated forms 
of MrgR.
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►Western blot showing the recognition of MBP-MrgR fusion protein by antibodies in convalescent sera pooled from 6 melio dosis patientsFigure 5
Western blot showing the recognition of MBP-MrgR fusion 
protein by antibodies in convalescent sera pooled from 6 
melioidosis patients. Lane 1: Uninduced cells, lane 2: cells 
induced for 3 h with IPTG, lane 3: amylose resin purified cell 
extract, lane 4: crude cell extract, and lane 5: insoluble mat-
ter, lane 6: purified maltose binding protein. Lane M: molecu-
lar weight markers indicated in kilodaltons (kDa).
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The full response regulator gene mrgR is present in the
genome of many B. mallei isolates but mrgS and the down-
stream flanking region are absent. Instead, ORFs immedi-
ately downstream of the mrgR homolog in B. mallei have
strong homology to penicillin amidase, carbamoyl trans-
ferase and transposase and their presence provides cir-
cumstantial evidence that transposition may partly
explain the absence of this region in B. mallei.
Restriction fragment length analysis of the mrgRS 
downstream flanking region
Three oligonucleotide probes, FR1, FR2 and FR3, covering
almost 5 kb of the B. pseudomallei genome downstream
from mrgRS (Figure 1) were used to investigate EcoRI
digests of genomic DNA from different B. pseudomallei
strains as well as B. thailandensis (Table 1). No signal was
obtained with any of the probes in any of the B. thailan-
densis isolates. Furthermore, this region is not present in
the recently completed B. thailandensis E264 genome
sequence [33] that is available on GenBank.
The FR1 probe spans the distal end of mrgS and 285 nucle-
otides further downstream from the mrgS stop codon
including an EcoRI site, and was expected to hybridise two
EcoRI genomic DNA fragments of 684 and 592 bp. These
two bands were present in most isolates of B. pseudomallei
except 392 and H55 which possessed the 592 bp fragment
only (data not shown). In isolate 392 this band is very
strongly stained and may represent a doublet. In addition,
H55 possessed an additional unique band of approxi-
mately 4.5 kb. There were no obvious variations in frag-
ment size between isolates in the adjoining region that
was probed with FR2 (data not shown). However, the
region probed with FR3, which lacked an internal EcoRI
site, revealed two distinct patterns between B. pseudomallei
isolates. One pattern indicated the presence of a single
band of ~1781 bp in seven isolates, while the other pat-
tern demonstrated a band of ~1421 bp in nine isolates
(Figure 8). To determine the reasons for the difference, we
sequenced this part of the genome of isolates possessing
each size of EcoRI fragment.
Alignment of 1472 nucleotides covering the same region
of the genomes of isolates 112 and 204 revealed 19 base
substitutions including one substitution of "A" for "G" at
position 1119 which introduces an EcoRI site within
ORF4 as described below (GenBank accession no.
DQ418487). An examination of the genome sequences of
B. pseudomallei that are available on GenBank showed that
8 of the 10 strains possess the same modification at this
position as isolate 112. Among all of the B. pseudomallei
isolates, including 112 and 204, there are between 4 and
19 nucleotide substitutions within this 1472 bp region.
Furthermore, isolates that possess the "A" substitution at
position 1119 have substantial modifications to
sequences flanking this region of the genome (Figure 1),
including the presence of a 450 bp insertion (between
nucleotides 9565 and 9566 of GenBank accession no.
DQ418486) encoding a product with homology to a bac-
teriophage phiE125 gp30 protein (GenBank accession no.
AF447491), and ~650 bp sequence homologous to muta-
tor type transposases from a wide variety of bacterial spe-
cies, including Ralstonia solanacearum, Pseudomonas
syringae, and B. thailandensis. The transposase is probably
inactive because of the organization of the sequence,
which includes at least 4 stop codons and incomplete
reading frames.
Among the isolates of B. pseudomallei that were examined
up to 16 nucleotide substitutions fall within ORF4 and
although most of these, including the "A" for "G" substi-
tution which introduces the EcoRI site described above, do
not alter the predicted primary translation there are from
2–4 conservative amino acid substitutions. Non-conserv-
ative substitutions which are present, G180E (6/12 iso-
lates) and V229A (10/12 isolates), flank the serine active
site and may have functional consequences (Figure 9).
Lipases hydrolyze long-chain acyl-triglycerides, a process
that usually involves activation of the enzyme at the lipid/
Expression of MrgS in B. pseudomallei 204 cultured under dif-ferent combinations of temperature, pH and NaCl concen-trationFigure 7
Expression of MrgS in B. pseudomallei 204 cultured under dif-
ferent combinations of temperature, pH and NaCl concen-
tration. Western blots of whole cell lysates were probed 
with anti-MrgS. The identity of each lane is indicated at the 
top. Lane M: molecular weight markers indicated in kilodal-
tons (kDa). Arrow indicates the expected position of the 118 
kDa MrgS protein.
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Southern blot hybridisation of EcoRI-digested genomic DNA from isolates of B. pseudomallei and B. thailandensis using oligonu-cleotide probe FR3Figur  8
Southern blot hybridisation of EcoRI-digested genomic DNA from isolates of B. pseudomallei and B. thailandensis using oligonu-
cleotide probe FR3. Lane M, λ-HindIII markers with molecular sizes (in kilobases) indicated on the left. Lane pMRG4 contains 
an 8.4 kb BclI fragment of the B. pseudomallei 204 genome spanning most of the mrgRS locus and 5 kb downstream, inserted in 
the phagemid pBK-CMV which was excised from λZAP Express and digested with EcoRI. See Table 1 for isolate details.
M M pM
RG
4
20
4
E8H1E2
55
19H
70
6
H5
5
E8
2
9798H2
D
11
2
2221
6
E2
56
39
2
42
6
44
8
57
6
23
9.4
kb
6.6
4.3
2.3
2.0
Alignment of lipases of B. pseudomallei isolates 112 and 204Figure 9
Alignment of lipases of B. pseudomallei isolates 112 and 204. Boxes enclose the "lid" motif (residues 112–127) and serine active 
site (residues 187–191). Asterisks mark the catalytic triad of serine, aspartic acid and histidine. +: conservative amino acid sub-
stitutions. Non-conservative amino acid substitutions are underlined. The 6 substitutions that are marked were also present in 
many of the B. pseudomallei genome sequences of 10 isolates that are available in GenBank: S47N: 10 isolates; I157V: 10 iso-
lates; G180E: 5 isolates; V229A: 9 isolates; N340D: 4 isolates; E346Q: 3 isolates. Other substitutions were also found occasion-
ally: S252F: 1 isolate; D341A: 1 isolate; V249L: 1 isolate.
+
+
+ +
*
*
*
Isolate
112     MATELDPPDSFDPFDSIDSYDLFDSLDERQTNFTLSCAMDWGQNIKSPTTDILGKLIIGY  60 
204     ----------------------------------------------N-------------  60 
112     LGKSTKTKNNRFSIVWGPAVYVDPLSGYAANVTAIFKNTSNDKDYRLAFSGTNPNSQFAD  120 
204     ------------------------------------------------------------  120 
112     IVIEDNDVKNLTPFSKYVSDCPPDALIANGTAKALDITLQTLPSNSSASLTDFLKNLPKG  180 
204     ------------------------------------V----------------------E  180 
112     STLTVTGHSLGGVLASTFALYFSQSSGYPFKNVFCHSFAAATAGNVAFVAYSDGSLTGKM  240 
204     ------------------------------------------------A-----------  240 
112     KRLWHRYDVIPSSWNLSTMNRIKYIYEPNLFPTEDFIRKIRKIVYYFSNKHIYYAQPGSL  300 
204     ------------------------------------------------------------  300 
112     DHSQQFELEGAYHSGFKVFTDEAGWQHTFGYLAPLSLTANDLNEGEPWQPSLGTLA  356 
204     ---------------------------------------D-----Q----------  356 
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water interface, and are known to facilitate the colonisa-
tion of plants by fungi and bacteria [47]. The active site is
hidden until activation occurs when the "lid" covering the
active site opens, exposes the active site catalytic triad, S-
D-H, and allows access to the substrate. Mutating specific
residues flanking the active site can affect this process, for
example by altering the enantiomeric selectivity of B. cepa-
cia lipase [48]. B. pseudomallei is often associated with dis-
ease among workers in rice fields in Thailand and it has
been suggested that it may interact closely with plants by
using a plant pathogen-like TTS gene cluster [49-51]. In
this case, the delivery of lipases could play an essential
role in the colonization of plants by B. pseudomallei.
Studies investigating the molecular diversity of different
isolates of B. pseudomallei using a wide variety of methods
have demonstrated that although distinct groupings can
be defined substantial diversity exists and many isolates
do not fall into readily definable groupings or clinical out-
comes [3]. Recently, whole genome DNA and RNA spot-
ted arrays have been used to examine large scale genomic
variation among different Burkholderia species [33,34].
This work has demonstrated the close relationship that
exists between the non-pathogenic environmental sapro-
phyte B. thailandensis, the obligate equine parasite B. mal-
lei and the opportunistic pathogen B. pseudomallei and
particularly between B. mallei and B. pseudomallei, sup-
porting work by Godoy et al. [52] who considered B. mal-
lei to be a clone of B. pseudomallei rather than a separate
species. Kim et al. [33] showed that the expression of a
substantial number of genes is highly conserved between
all 3 species and suggested that the evolution of small sets
of genes rather than large scale acquisitions and losses
define the different adaptations of each species. On the
other hand, Ong et al. [34] proposed that the same 3 spe-
cies may have diverged through the loss of large chromo-
somal segments and defined 3 distinct molecular
subtypes of B. pseudomallei on the basis of regions of dif-
ference, constituting areas of DNA recombination that are
often characterized by open reading frames (ORFs)
encoding products related to phage proteins, transposase
or integrase proteins. However, apart from rRNA genes
[53] few studies have assessed the extent of variation at
specific loci in B. pseudomallei.
The diversity of organisms in tropical countries in which
melioidosis is endemic and the frequent interactions that
may be possible in that environment and within the
human host could create opportunities for genetic change
[54]. However, a mutation that confers a selective advan-
tage in one environment is unlikely to be a benefit in all
environments [55]. Winstanley et al. [56] assessed the
extent of variation in the flagellin genes of B. pseudomallei
by comparing the sequences that were obtained from
environmental and clinical isolates of the pathogen. The
sequences showed either 100% identity or differed by a
single nucleotide demonstrating a remarkably conserva-
tive nature in these genes. Here, we found a consistent var-
iation in a small region of the B. pseudomallei genome
downstream from the mrgRS locus involving up to 19
nucleotide substitutions including one which changes
GAGTTC to GAATTC, the recognition sequence for the
restriction enzyme EcoRI. The consequent restriction frag-
ment length polymorphism (RFLP) was shown to sepa-
rate B. pseudomallei isolates from clinical and
environmental sources and from spatially and temporally
separate origins, into two distinct groups of almost equal
proportions. There was no apparent association between
the source of the isolates, the date and place of isolation,
and the RFLP pattern. Nevertheless, the substitutions rep-
resent a stable genetic modification since they have been
retained over time. Furthermore, a search of the genome
sequences for B. pseudomallei isolates that are available on
GenBank revealed the presence of the same modification
in many of the isolates. While it is possible that these
sequence differences may have occurred at random, the
almost equal distribution of the polymorphism among
the isolates, the presence of a 450 bp insertion and the
close proximity of an inactive transposase suggest that it is
much more likely that some process of selection has
occurred. For example, differences in primary or second-
ary host factors may act to select isolated subpopulations
according to transmission route or host immune geno-
types and play a role in the selection for a mutation or
recombination event arising within a bacterial population
[57,58]. How this may have occurred in the isolates we
examined here is not known. Ong et al. [34] described B.
pseudomallei strain subtypes isolated from different pri-
mary hosts, pigs (G1 strains) and melioidosis patients
(G2 strains), and so we propose that a selective process
involving primary hosts or other vectors, including amoe-
bae, fungi or plants [59-61], may have played a role.
Conclusion
This work was initiated and completed well before the B.
pseudomallei genome sequence was published. Although
the completion of the B. pseudomallei genome sequence
has provided a huge body of annotated nucleotide
sequence data and an examination of this data revealed at
least 33 potential two-component systems in the
sequence annotations, very few of the putative genes have
been specifically confirmed to be expressed at the protein
level in different B. pseudomallei strains. In fact, there are
substantial discrepancies in the gene and protein annota-
tions for the completed genome sequences of B. pseudoma-
llei isolates K96243 and 1710b that are available on the
GenBank database. Our work demonstrates that mrgR and
mrgS are present and expressed as protein in a variety of B.
pseudomallei isolates and that the expression of the locus is
temperature-regulated which is an essential step that must
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be completed before pursuing more complex studies
aimed at understanding the biological function and path-
ogenic significance of the mrgRS locus. A similar approach
will be necessary to prove the specific protein expression
of each of the putative genes that have been identified in
the B. pseudomallei genome rather than simply assuming
that all open reading frames that are annotated in the
nucleotide sequence of the genome are expressed as the
conceptually translated protein.
Because of its' nutritional and environmental adaptabil-
ity, B. pseudomallei has the potential to spread to areas of
the world outside southeast Asia and northern Australia.
Two-component transduction systems are a major mech-
anism by which bacteria regulate adaptive responses to
environmental stimuli [18]. Although there have been
extensive studies of the biology of B. pseudomallei, very few
of these have investigated the influence of environmental
factors on gene expression and the adaptive responses of
the bacterium. We have identified and characterized a
two-component transduction system from B. pseudomallei
that is present and expressed in a variety of strains of the
bacterium, encoding proteins that are most similar to the
regulators of capsular synthesis in other bacteria. In B.
pseudomallei, the expression of these proteins is regulated
in response to temperature rather than pH or salinity and
they are more strongly expressed at temperatures found in
mammalian and avian hosts. The recognition of MrgR by
antibodies in convalescent sera from melioidosis patients
suggests that the mrgRS locus may have a role in regulating
adaptive responses during the course of infection. Because
the expression of the genes is increased at higher temper-
atures then the adaptive responses they control may be
particularly important during the initial phases of infec-
tion.
It has been proposed that B. mallei, B. pseudomallei, and B.
thailandensis represent 3 states of ecological niche adapta-
tion, namely, obligate pathogen, opportunistic pathogen,
and saprophyte, respectively [33]. The 3 species are very
closely related and the mechanisms of evolutionary diver-
gence are subject to debate [33,34,52]. The absence of the
mrgRS locus and downstream flanking region from the
genome of B. thailandensis shows that it is not essential for
a non-pathogenic existence. Because of the similarities in
gene organization and structure with other signal trans-
duction systems involved in phase change and the regula-
tion of virulence gene expression, it is possible that mrgS
and the downstream ORFs may have a similar role in
adaptive responses of B. pseudomallei, which in the case of
mrgS is regulated by changes in temperature. The absence
of this region in B. mallei suggests that this function is no
longer required but mrgR may still have a regulatory role.
Nucleotide sequence accession numbers
[GenBank:DQ418486, GenBank:DQ418487]
Methods
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1. All
strains of Burkholderia species were grown at 37°C, except
B. plantarii and B. vandii which were grown at 25°C, on
Luria-Bertani (LB) agar or broth, statically. Pseudomonas
aeruginosa and Pseudomonas fluorescens were grown on
nutrient agar at 37°C. The identity of B. pseudomallei was
confirmed by the API 20NE biochemical test [62]. For
expression studies, 10 ml LB broths containing NaCl
(0.15, 0.5 or 2.2% w/v) were adjusted to pH 5, 6.8 or 8
and a standardized inoculum of 107 cells was added and
incubated for 48 h at 25, 37 or 42°C. E. coli strains were
cultured on LB agar or broth [63] and when required, cul-
ture media were supplemented with IPTG (100 μM), X-gal
(100 μg ml-1), ampicillin (100 μg ml-1), chloramphenicol
(25 μg ml-1) or kanamycin (25 μg ml-1).
DNA manipulations
Restriction enzyme digestions, DNA blunting and kinas-
ing, DNA ligation, bacterial transformation and DNA
hybridisation were performed according to standard
methods [63]. Plasmid DNA was isolated using the Mini-
prep plasmid DNA extraction kit (BioRad), lambda DNA
was purified using the Wizard λ prep DNA purification kit
(Promega) and DNA fragments, PCR products and liga-
tion mixtures were recovered using the Prep-a-gene DNA
purification kit (BioRad). Genomic DNA was extracted
using the Puregene D-6000 DNA isolation kit (Gentra Sys-
tems) and quantified by comparison with lambda DNA
standards (Sigma Aldrich) using digital images of 1% aga-
rose gels stained with ethidium bromide.
Preparation of oligonucleotide probes
PCR primers (Sigma Genosys), 5'-GATTTCACGATGCAT-
CAGGCGAAC-3' and 5'-TTCTGGATCGCCGCGATGTC-
CGTG-3', were derived from the sequences of response
regulator genes from other bacterial species to amplify a
377 bp sequence from B. pseudomallei 204 genomic DNA.
The PCR reaction contained 1 unit Taq DNA polymerase
in reaction buffer (Roche), 1.5 mM MgCl2, 10 pmol of
Table 2: PCR primers for preparing oligonucleotide probes FR1, 
FR2, and FR3
Primer Sequence 5'-3'
FR1 forward ATGATGGACGGTTTCCAGTTGCTC
FR1 reverse AACGTTAAATCAAGTCGCGGGTGG
FR2 forward AGAGCGCTGTCGCAACTGAATCTG
FR2 reverse TCGCTTCGCTTGCTGAGAAA
FR3 forward GGTCCGGGCCAAATATTACGATCC
FR3 reverse AGCGGAACCAATCCGAACTCACAG
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each primer, 0.2 mM of each dNTP and 10 ng genomic
DNA. Reactions were placed at 96°C for 2 min, followed
by 35 cycles consisting of 96°C for 30 s, annealing at
45°C (1st cycle), 50°C (2nd and 3rd cycles) and 60°C
(remaining 33 cycles) for 30 s, 72°C for 90 s and a final
extension at 72°C for 5 min. Amplicons were analysed in
1% agarose gels, purified and subcloned into pUC18
using E. coli DH5α. Cloned DNA was fully sequenced in
both directions (MWG Biotech). Following confirmation,
the insert was excised from pUC18 by EcoRI and PstI diges-
tion, purified by agarose gel electrophoresis and labelled
with digoxigenin-11-dUTP (Roche).
For RFLP analysis of 4994 bp of the genome downstream
from the mrgRS locus, three pairs of PCR primers (Table
2) were designed on the basis of nucleotide sequence data
(GenBank accession no. DQ418486) to amplify oligonu-
cleotide probes to sequentially examine 5 contiguous
EcoRI fragments of the genome. The probes were desig-
nated FR1, a 665 bp probe targeting a 1276 bp segment
with an internal EcoRI site and including the mrgS stop
codon, FR2, a 1062 bp probe targeting a 1937 bp segment
with an internal EcoRI site, and FR3, a 1136 bp probe tar-
geting a 1781 bp segment. The PCR reaction contained 1
unit Taq polymerase in reaction buffer (Roche), 1.5 mM
MgCl2, 24 pmol of each primer, 0.2 mM of each dNTP and
10 ng genomic DNA. Reactions were placed at 96°C for 2
min, followed by 35 cycles of 96°C for 40 s, 65°C for 40
s, 72°C for 90 s and a final extension at 72°C for 5 min.
Amplicons were analysed in 1% agarose gels, purified and
subcloned into pUC18 using E. coli DH5α. Cloned DNA
was fully sequenced in both directions (MWG Biotech)
and was labelled with digoxigenin-dUTP (Roche).
Construction and screening of genomic DNA libraries
B. pseudomallei 204 chromosomal DNA libraries were con-
structed using λGEM-11 and λZAP Express vectors. For
λGEM-11, genomic DNA was partially digested with
Sau3A to yield fragments between 9 and 23 kb which were
inserted into the BamHI site and packaged recombinants
were plated on E. coli LE392 using NZCYM-agarose con-
taining 0.2% maltose (Promega). For λZAP Express,
genomic DNA was completely digested with BclI and
ligated into the BamHI site, packaged, and propagated on
E. coli XL1-Blue. Plasmid DNA, in the form of the kanamy-
cin-resistant phagemid pBK-CMV, containing cloned
DNA inserts was excised from λZAP Express using helper
phage and E. coli XLOLR (Stratagene).
For screening B. pseudomallei genomic libraries, phage
plaques were overlaid with gridded nitrocellulose filters
(Schleicher and Schuell) for 30 min at 4°C. Filters were
processed for hybridization with a labelled oligonucle-
otide probe at high stringency overnight at 68°C accord-
ing to standard methods [63]. Positive phage plaques
were detected with anti-digoxigenin antibody (Roche).
DNA sequencing and sequence analysis of cloned products
Both strands of cloned DNA were sequenced (MWG Bio-
tech) using either M13 universal and reverse primers or
custom synthesized primers (Sigma Genosys). Gene
sequences have been deposited in the GenBank database
(GenBank accession nos. DQ418486, DQ418487). Gene
promoter predictions were made using software provided
by Berkeley Drosophila Genome Project [64]. Homology
and conserved domain searches were conducted using
BLAST software provided by NCBI [65]. Software pro-
vided by the Swiss Institute of Bioinformatics [66] and
Institut Pasteur [67] was used to analyse secondary struc-
ture (PHDtopology), hydrophobicity (Pepwindow),
helix-turn-helix motifs (Helixturnhelix), and transmem-
brane regions (TopPRED2, DAS). Multiple amino acid
sequence alignments were performed using MultAlin soft-
ware [68]. SecretomeP 2.0 [44] was used to predict non-
classical protein secretion [69].
Southern blotting
Genomic DNA (3 μg) was completely digested with EcoRI
and the fragments separated in 1% agarose gels in TBE
buffer, depurinated, denatured and neutralized using
standard methods [63]. DNA was capillary blotted onto
positively charged nylon membranes (Amersham Bio-
sciences) and fixed to the membrane using UV irradiation.
The blots were prehybridized, hybridized with the
labelled oligonucleotide probe and developed, according
to standard methods [63].
Synthetic peptides and production of affinity purified 
antibodies
Synthetic peptides consisting of 9 amino acid residues,
DTNVDLINC and RKFYSLESN, corresponding to amino
acids 206 to 214 located toward the C-terminus of MrgR
Table 3: Dilutions of primary and secondary antibodies for Western blotting
Primary Antibody Dilution Secondary Antibody Dilution Source
Anti-MrgR 1:500 Swine Anti-rabbit IgG 1:2000 Bethyl Labs
Anti-MrgS 1:300 Swine Anti-rabbit IgG 1:1000 Bethyl Labs
Anti-MBP 1:1000 Swine Anti-rabbit IgG 1:2000 NEB
Convalescent sera pooled 
from 6 melioidosis patients
1:300 Rabbit Anti-human IgG 1:1000 Ty Pitt, HPA, London
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and amino acids 14 to 22 located in the N-terminus of
MrgS, respectively, were synthesized, conjugated to key-
hole limpet hemocyanin (KLH) and used to immunize
rabbits (Bethyl Laboratories). To facilitate coupling to
maleimide-activated KLH a glycine residue was attached
to the C-terminus of the MrgR oligopeptide and a cysteine
residue was attached to the N-terminus of the MrgS oli-
gopeptide. Antibodies were purified from the hyperim-
mune serum of immunized rabbits by affinity
chromatography using a peptide-Sepharose matrix, filter
sterilized and stored at 4°C. The affinity purified antibod-
ies, anti-MrgR and anti-MrgS, were tested for antigen rec-
ognition and specificity as described in Additional file 1,
Additional file 2 and Additional file 3.
Preparation of B. pseudomallei protein samples and 
Western blotting
Cells from 1 ml aliquots of B. pseudomallei cultures that
had been prepared as described above were centrifuged
(4,000 g, 10 min, 4°C), washed in PBS and resuspended
in lysis buffer (0.75 M Tris-HCl pH 8.8 containing 0.2%
SDS). B. pseudomallei broth culture supernatants contain-
ing extracellular products (ECPs) were centrifuged
(15,000 g, 10 min, 4°C) and the supernatant was concen-
trated 250-fold using Amicon Minicon Miniplus units, 10
K nominal mw cutoff (Millipore). The total protein con-
centration of cell lysates and ECPs was determined using
a protein assay kit (Bio-Rad). Lipase activity in the concen-
trated supernatants was determined by comparison with
uninoculated broth using the fluorogenic substrate 4-
methylumbelliferyl oleate (Sigma). For each sample,
equivalent amounts of B. pseudomallei whole cell lysate (5
μg) or ECPs (2 μg), were diluted in Laemmli buffer and
separated on 12% polyacrylamide-SDS gels. Proteins were
electrotransferred to nitrocellulose membranes under
standard conditions [70]. Membranes were blocked for 2
h in PBS containing 1% casein, incubated overnight with
the primary antibody diluted in the blocking solution,
washed 3 × 10 min, and then incubated for 2 h at room
temperature in secondary antibody conjugated to horse-
radish peroxidase (Dako A/S). A list of the primary and
secondary antibodies and dilutions that were used is pro-
vided in Table 3.
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